Trump's historic announcement: The U.S. allows the use of blood plasma for treating coronary patients

The U.S. Food and Drug Administration (FDA) has provided emergency authorization to use plasma to treat patients with Ovid. The technique uses blood plasma rich with antibodies from people who have recovered from the disease and has already applied to 70 thousand people in the United States in testing, or even to the people of [...]
The technique uses blood plasma rich with antibodies from people who have recovered from the disease and has already applied to 70 thousand people in the United States in testing, or even to seriously ill people.
The FDA says initial tests show that it's a safe technique, although more tests are needed to test their efficiency, Writes BBC, translates Periscope.
The announcement came just a day after President Donald Trump accused him The FDA for obstructing the development of vaccine and therapeutic treatments for political reasons, and on the eve of the Republican National Convention, where it will launch its campaign to win a second mandate at the White House.
This is what I've been wanting to do for a long time,” the president told reporters yesterday.
I am very pleased to make a truly historic announcement in our battle against the Chinese virus that will save countless lives. ”
Mr. Trump described the procedure as a powerful therapy until he appealed to Americans who had passed the coronary to donate their plasma. /Periscope












